Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodayPrecious Metals
Gold Price TodayNew
Silver Price TodayNew
Platinum Price TodayNewSmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹- Cr
Market Cap
Total market value of companyP/E Ratio
-
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
-
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹0.00
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
-%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
-%
ROCE
Return on Capital Employed. >15% is goodNet Margin
-%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
-%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
-%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
-
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹-
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
0.00%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
No data availableWeaknesses
3 points- •The absence of key financial data, such as the Price-to-Earnings ratio (P/E), Return on Equity (ROE), and Debt-to-Equity ratio, prevents a proper assessment of AMIORG's financial health and profitability. This lack of transparency is a major concern for potential investors.
- •The reported market capitalization and current stock price are both 0.00, indicating severely incomplete or missing data. This critical data gap makes any meaningful financial analysis impossible and raises serious questions about data reliability.
Opportunities
2 points- •The relatively stable stock price over the past five days, fluctuating between approximately 1160 and 1200, suggests potential for future growth, although this needs to be confirmed with more complete financial data.
- •High daily trading volumes, ranging from 242,994 to 455,735 shares, indicate significant market interest in AMIORG. This could be leveraged to attract further investment if the company addresses its data transparency issues.
Threats
2 points- •The complete absence of essential financial metrics, including profitability ratios and debt levels, presents a significant threat. Without this information, investors cannot accurately assess the company's risk profile and potential for future returns.
- •The lack of transparency regarding key financial data and promoter holdings creates significant uncertainty and risk for potential investors. This lack of information could deter investment and negatively impact the company's valuation.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹1213.43 | +₹37.13 | +3.16% |
| R3 | ₹1198.73 | +₹22.43 | +1.91% |
| R2 | ₹1191.77 | +₹15.47 | +1.31% |
| R1 | ₹1184.03 | +₹7.73 | +0.66% |
| PIVOT | ₹1177.07 | 0.77 | 0.07% |
| CURRENT | ₹1176.30 | - | - |
| S1 | ₹1139.93 | -₹36.37 | -3.09% |
| S2 | ₹1154.63 | -₹21.67 | -1.84% |
| S3 | ₹1162.37 | -₹13.93 | -1.18% |
| S4 | ₹1169.33 | -₹6.97 | -0.59% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-57.3% vs avg
2.43L
(30 May 2025)Delivery %+17.1% vs avg
69.1%
(30 May 2025)Avg Volume (20D)20-day average
5.69L
(05 May - 30 May)Avg Delivery %Trend ↑
52.0%
(05 May - 30 May)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
No peer comparison data available
About
Acutaas Chemicals Limited (formerly Ami Organics Limited) is a prominent player in the pharmaceutical and specialty chemical industry, headquartered in Surat, India. Their core business revolves around the research, development, manufacturing, and global distribution of pharmaceutical intermediates. These intermediates serve as crucial building blocks in the synthesis of a wide range of active pharmaceutical ingredients (APIs).
A significant portion of Acutaas's pharmaceutical intermediate production caters to the creation of APIs for various therapeutic applications. This includes anti-retroviral drugs used to combat HIV/AIDS, anti-inflammatory medications for reducing swelling and pain, anti-psychotics for managing mental illnesses, anti-cancer agents for treating malignancies, anti-Parkinson's drugs to alleviate Parkinson's disease symptoms, antidepressants used to treat depression, and anticoagulants to prevent blood clots. Furthermore, they contribute to the development of new chemical entities (NCEs), representing cutting-edge advancements in pharmaceutical research.
Beyond the pharmaceutical sector, Acutaas Chemicals Limited also manufactures and supplies specialty chemicals to other industries. These include agrochemicals (for agriculture), cosmetics (for beauty and personal care products), and polymers (used in various materials). Specific examples of these specialty chemicals include parabens (preservatives), salicylic acid (used in various applications), and other specialized compounds employed in cosmetics, dyes, polymers, agrochemicals, animal feed, and personal care products.
The company boasts a substantial export business, distributing its pharmaceutical intermediates and specialty chemicals to customers across the globe. Its history dates back to 2004, demonstrating a long-standing commitment to innovation and quality within the chemical manufacturing sector. The name change to Acutaas Chemicals Limited occurred in May 2025, signifying a potential rebranding or strategic shift in the company's focus, although the core business activities remain largely unchanged.
COMPANY FACTS - AMIORG
Registered Address
Company Details
Investor Questions Answered
Stock (AMIORG) Stock FAQs
Get answers to the most common questions about Stock stock price, fundamentals, financial metrics, and investment analysis
The current share price of this stock (AMIORG) is ₹1,176.3. Today, the stock has declined by ₹3.60 (0.31%), trading in a range of ₹1,170.1 to ₹1,184.8. The stock opened at ₹1,179.9 with a trading volume of 2,42,994 shares.
this stock can be considered for long-term investment based on several factors. The company has a market capitalization of ₹0 crores, P/E ratio of 0.00, ROE of 0.00%, and ROCE of 0.00%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of this stock (AMIORG) is ₹1,212.9, while the 52-week low is ₹1,123. Currently trading at ₹1,176.3, the stock is 59.3% away from its 52-week low and 3.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy this stock stock at ₹1,176.3 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of N/A. Today's performance shows a loss of 0.31%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
this stock offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹1,176.3, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹0.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
this stock's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: N/A, ROE: 0.00%, ROCE: 0.00%, Dividend Yield: 0.00%, EPS: ₹0.00, Book Value: ₹0, Debt-to-Equity: 0.00, and Current Ratio: N/A. The company's market cap stands at ₹0 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
this stock stock opened at ₹1,179.9 and is currently trading at ₹1,176.3, showing a decline of ₹3.60 (0.31%). The intraday high is ₹1,184.8 and low is ₹1,170.1. The trading volume stands at 2,42,994 shares, indicating moderate market participation today.
this stock has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹0.00, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
this stock has a market capitalization of ₹0 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,176.3) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
this stock has a book value of ₹0 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹1,176.3, which is Infinity% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
this stock has a Return on Equity (ROE) of 0.00% and Return on Capital Employed (ROCE) of 0.00%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
this stock operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
this stock has a debt-to-equity ratio of 0.00, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
this stock has an Earnings Per Share (EPS) of ₹0.00, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹1,176.3 and P/E ratio of 0.00, investors are paying 0.00 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
this stock has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
this stock has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze this stock stock, consider: 1) Fundamental Analysis - Review P/E (0.00), ROE (0.00%), debt-to-equity (0.00), and growth rates. 2) Technical Analysis - Check 52-week range (₹1123.00 - ₹1212.90), moving averages, and chart patterns. 3) Valuation - Compare current price (₹1176.30) with book value (₹0.00) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of this stock share is ₹0.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹1,176.3 is Infinityx the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in this stock carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹1123.00 - ₹1212.90). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.00 indicates leverage. 4) Liquidity Risk - Based on trading volume of 2,42,994 shares. 5) Valuation Risk - P/E of 0.00 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
this stock operates in the industry with key metrics: P/E ratio of 0.00, ROE of 0.00%, market cap of ₹0 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.00), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for this stock vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹1,176.3, with a 52-week range of ₹1123.00 to ₹1212.90. Based on fundamentals like P/E (0.00), ROE (0.00%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling this stock stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹1176.30. 2) Fundamental Deterioration - Declining ROE (currently 0.00%), increasing debt (D/E: 0.00), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for this stock stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu